EPISODIC MIGRAINE
Clinical trials for EPISODIC MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new EPISODIC MIGRAINE trials appear
Sign up with your email to follow new studies for EPISODIC MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New migraine pill shows Long-Term safety in 3-Year study
Disease control CompletedThis study looked at the long-term safety of a daily pill called atogepant for preventing migraines. About 600 adults with chronic or episodic migraine took the drug for up to 156 weeks (about 3 years). The main goal was to see how many people had side effects. This was an extens…
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
Daily pill shows promise for preventing migraines in safety study
Disease control CompletedThis study looked at the safety of taking rimegepant every day to prevent episodic migraines. 441 adults with a history of migraines took the pill daily and were monitored for side effects. The main goal was to see how well people tolerated the medication over time, not to measur…
Matched conditions: EPISODIC MIGRAINE
Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control
Last updated May 15, 2026 11:53 UTC